Trump’s Drug Price Initiative Has No Impact On Most US Patients’ Costs

President Donald Trump speaks in the Oval Office of the White House in Washington, DC, on Tuesday, Sept. 30, 2025, on a deal with the drug company Pfizer to sell some of its drugs at discounts (supposedly reflecting “most favored nation” prices or the lowest among U.S. peers) on a direct-to-consumer federal government website called TrumpRx as well as to Medicaid. Photographer: Francis Chung/Politico/Bloomberg

© 2025 Bloomberg Finance LP